Skip to main content
Premium Trial:

Request an Annual Quote

Genomics Shares Higher Following Celera Announcement

NEW YORK, Feb 12 – News that Celera had published its human genome sequencing paper in Science and made its data available on its website helped to bolster genomics stocks Monday morning.

Shares of Celera jumped 3.3, or 7.9 percent, to 44.90 in morning trading, while shares of sister company Applied Biosystems were also up, rising 3.49, or 4.8 percent, to 76.40.

Celera’s main competitor in the data war, Incyte, was also up, albeit a more moderate 5/16, or 1.5 percent, at 20 13/16.

Shares of genomics drug-discovery companies Human Genome Sciences and Millennium were also higher in morning trading. Shares of Human Genome Sciences jumped 3 1/4, or 6.4 percent, to 54 5/16. Millennium’s shares were up 2 1/16, or 5.0 percent, at 43.

Genomics technology companies were also higher following the reactions to the morning announcement. Bioinformatics player Lion Biosciences was up 1 1/4, or 2.2 percent, at 59 1/4, while DNA chipmaker Affymetrix was up 4 3/32, or 6.5 percent, at 66 11/16. 

But Third Wave Technologies, a maker of SNP detection tools, was down in its second day of trading. Shares were off 1/16, or 0.6 percent, at 11.

On Friday, Third Wave offered 7.5 million shares at $11 each. The company’s stock closed the day up 6 cents at $11.06.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.